GGyala Therapeutics — Seed · €1.5M
Gyala Therapeutics, a spin-off of Hospital Clínic-IDIBAPS developing new CAR-T therapies for blood cancers, raised €1.5M in seed financing from Invivo Ventures.
LeadInvivo Ventures
RoundSeed
Announced26 May 2020
CityBarcelona
SectorHealthtech & Bio · Biotech
Source
I
H
I
H